Conexeu Sciences is trading at $3.50, up 5.74% in after-hours trading; available information does not establish why the price moved higher.

  • The rise followed a $3.31 close, down 12.20% that session.
  • No new company announcement or clear company-specific catalyst was identified for October 13. The latest update, on October 6, covered work toward a planned FDA 510(k) submission in Q1 2027.
  • Broader market indices were mixed, with none moving more than 0.5% in the same direction as the after-hours gain.